← Leaderboards
Inna Serganova
Sloan-Kettering Inst Can Research
$1,427,978
Attributed
$1,427,978
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $228.3K · FY2018–25$250K$187.5K$125K$62.5K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,427,978 · 1
By mechanism
R50$1,427,978 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Andrew Michael Intlekofer$5,190,407
- Jan Grimm$17,140,928
- Nagavarakishore Pillarsetty$8,324,037
- Timothy An-Thy Chan$21,076,830
- Isabelle Riviere$12,156,024
Others in their field
Other Emerging Leaders on “T-Lymphocyte”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Crystal Mackall · Children'S Hosp Of Philadelphia$16,367,876
- Wilton B Williams · Duke University$16,226,847
- Gary Fanger · Rise Therapeutics, Llc$15,372,982
- Aaron Esser-Kahn · University Of Chicago$13,378,548
Research focus
T-LymphocyteFundingPathway InteractionsT Cell TherapyTumor MetabolismImmuneNeoplasm MetastasisNovel Therapeutic InterventionScientistT Cell ResponseTraffickingTumorTumor MicroenvironmentWagesAffectMetabolicNeoplastic CellCellsAwardGrantSpecialistCancer ImagingImmune CheckpointImmune Checkpoint Blockade
Grant awards (8)
Exploiting tumor metabolism to optimize T cell therapy$177,500
R50 · FY2025 · CA · contact PI
Exploiting tumor metabolism to optimize T cell therapy$177,500
R50 · FY2024 · CA · contact PI
Exploiting tumor metabolism to optimize T cell therapy$215,438
R50 · FY2022 · CA · contact PI
Exploiting tumor metabolism to optimize T cell therapy$182,756
R50 · FY2021 · CA · contact PI
Exploiting tumor metabolism to optimize T cell therapy$137,215
R50 · FY2020 · CA · contact PI
Exploiting tumor metabolism to optimize T cell therapy$91,060
R50 · FY2020 · CA · contact PI
Exploiting tumor metabolism to optimize T cell therapy$228,275
R50 · FY2019 · CA · contact PI
Exploiting tumor metabolism to optimize T cell therapy$218,234
R50 · FY2018 · CA · contact PI